After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricingJune 16, 2023Business of MedicineAnkylosing spondylitisRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatrics
Is ChatGPT a friend or foe of medical publishing?June 9, 2023Business of MedicineRheumatoid Arthritis
When could you be sued for AI malpractice? You’re likely using it nowJune 8, 2023Business of Medicine
The enemy of carcinogenic fumes is my friendly begoniaJune 8, 2023LOTMEMixed TopicsBusiness of Medicine
States move to curb insurers’ prior authorization requirements as federal reforms lagMay 26, 2023Business of Medicine
People still want their medical intelligence in human formMay 25, 2023LOTMEMixed TopicsBusiness of MedicineImaging
